Know Cancer

or
forgot password

    • cancer clinical trials in boise, ID

    • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Melanoma (Skin)
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    St. Luke's Regional Medical Center
    Boise, Idaho 83712
    Breast Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    St. Luke's Mountain States Tumor Institute - Boise

    Trial Locations
    St. Luke's Mountain States Tumor Institute - Boise
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Lymphoma
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    St. Luke's Mountain States Tumor Institute - Boise
    Boise, Idaho 83712-6297
    Breast Cancer
    STI571 in Treating Patients With Recurrent Leukemia
    Mountain States Tumor Institute
    Boise, Idaho 83712
    Leukemia
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    Mountain States Tumor Institute
    Boise, Idaho 83712
    Brain and Central Nervous System Tumors
    S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Lymphoma
    Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Sarcoma
    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Prostate Cancer
    Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
    St. Luke's Mountain States Tumor Institute - Boise
    Boise, Idaho 83712-6297
    Multiple Myeloma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Esophageal Cancer, Gastric Cancer
    Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    St. Luke's Mountain States Tumor Institute - Boise

    Trial Locations
    St. Luke's Mountain States Tumor Institute - Boise
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Breast Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Brain Tumor, Central Nervous System Tumor
    PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
    St. Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Pancreatic Cancer
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Mountain States Tumor Institute - Boise
    Boise, Idaho 83712
    Kidney Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Leukemia
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Leukemia
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Multiple Myeloma and Plasma Cell Neoplasm
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    St Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Chronic Lymphocytic Leukemia
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Lymphoma
    Radiation Therapy in Treating Young Patients With Gliomas
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Brain Tumor, Central Nervous System Tumor
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Colorectal Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Prostate Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Luke's Mountain States Tumor Institute
    Prostate Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Alphonsus Regional Medical Center

    Trial Locations
    Saint Alphonsus Regional Medical Center
    Saint Luke's Mountain States Tumor Institute
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Kidney Cancer
    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor